Oculis to Participate at the Piper Sandler Virtual Ophthalmology Conference
Oculis Holding AG announced participation in the Piper Sandler Virtual Ophthalmology Conference, where management will provide updates on its late-stage drug candidates Privosegtor and Licaminlimab targeting significant unmet needs in neuro-ophthalmic and ophthalmic diseases. With regulatory designations and ongoing registrational trials, the compa…